Avanir Pharmaceuticals Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover

NEW YORK, Dec. 4, 2014 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) in connection with a buyout for only $17.00 per share. Concerned AVNR investors are encouraged to contact attorney Hamilton Lindley by clicking here.

The investigation focuses upon the shareholder value of the transaction. This offer appears to deeply discount the chances of success in Alzheimer's agitation, and Jefferies has valued the stock at $26.00 to $31.00 in the event of an acquisition. The firm's potential shareholder lawsuit will seek to obtain the highest price reasonably available and that all important information about the deal is disclosed.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. AVNR stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/AVNR.

Hamilton Lindley
Dunnam Dunnam Harmon West Lindley & Ryan LLP
4125 W. Waco Drive
Waco, TX 76710
(844) 702-2990 Toll Free
(254) 753-6437 Telephone
(254) 753-7434 Facsimile
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-inc-stockholders-encouraged-to-contact-securities-law-firm-about-takeover-300004946.html

SOURCE Dunnam & Dunnam

Related Links

http://www.dunnamlaw.com